Portland’s attempt to incentivize housing construction is beginning to pay off – maybe. In a memo sent to Portland city councilors on Friday, city officials said the city “is seeing some promising ...

Economic development legislation championed by Oregon Gov. Tina Kotek is poised to dramatically expand the state’s tax breaks for data centers, which are already among the largest in the nation.

TUCSON, Ariz. (KVOA) - Pima County is set to implement a sliding scale fee for the Pima Early Education Program (PEEPs) targeting families at the higher end of the income eligibility scale, according ...

Farm management analyst Kent Thiesse answers some of the farm program and crop insurance questions that have resulted from the implementation of the One Big Beautiful Bill Act. Some of the farm ...

Leveraging tools from seismology — the study of earthquakes and the inside of our planet — the Earth Rover Program aims to provide critical data on the health of soil. Humans, and terrestrial life in ...

Prudential Advisors intends the updates, including some related to artificial intelligence, to improve processes across the full lead life cycle. The retail arm of Prudential Financial Inc.—Prudential ...

It takes a lot to shock me anymore. I’ve covered the Washington government for years. I understand rounding errors. I get that numbers shift, estimates change, projections don’t always pan out. That’s ...

Store loyalty programs used to be simple: You’d get a punch card at a local sub shop, buy eight sandwiches and get your ninth for free. It felt like a transparent “thank you” for your business. But ...

The last time I wrote an article on Structure Therapeutics Inc. (GPCR) it was in a Seeking Alpha article entitled "Structure Therapeutics: Potential To Have Best-In-class GLP-1 Agonist For Obesity ...

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...

SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...